Shock waves induce activity of human osteoblast-like cells in bioactive scaffolds

Journal of Trauma - Injury, Infection and Critical Care

Volumn 68, Issue 6, 2010, Pages 1439-1444

  Muzio, Giuliana ^a   Vernè, Enrica ^b   Canuto, Rosa Angela ^a   Martinasso, Germana ^a   Saracino, Silvia ^a   Baino, Francesco ^b   Miola, Marta ^b   Berta, Laura ^a   Frairia, Roberto ^a   Vitale Brovarone, Chiara ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b POLITECNICO DI TORINO   (Italy)

Author keywords

BMP; Osteoblasts; Scaffold; SEM; Shock waves

Indexed keywords

ARTICLE; BONE REGENERATION; HUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROSTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; SHOCK WAVE;

ANALYSIS OF VARIANCE; BONE REGENERATION; CELL LINE; CERAMICS; GLASS; HIGH-ENERGY SHOCK WAVES; HUMANS; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; OSTEOBLASTS; POLYURETHANES; POROSITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE SCAFFOLDS;

EID: 77953809343     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181b28a8c     Document Type: Article

References (28)

1. Lee YM, Seol YJ, Lim YT, et al. Tissue-engineered growth of bone by marrow cell transplantation using porous calcium metaphosphates matrices. J Biomed Mater Res. 2001;54:216-233.
2. Navarro M, del Valle S, Martínez S, et al. New macroporous calcium phosphate glass ceramic for guided bone regeneration. Biomaterials. 2004;25:4233-4241. (Pubitemid 38388584)
3. Sepulveda P, Jones JR, Hench LL. Bioactive sol-gel foams for tissue repair. J Biomed Mater Res. 2002;59:340-348.
4. Martina M, Subramanyam G, Weaver JC, Hutmacher DW, Morse DE, Valiyaveettil S. Developing macroporous bicontinuous materials as scaffolds for tissue engineering. Biomaterials. 2005;26:5609-5616.
5. Green D, Walsh D, Mann S, Oreffo RO. The potential of biomimesis in bone tissue engineering: lessons from the design and synthesis of invertebrate skeletons. Bone. 2002;30:810-815.
6. Aichelmann-Reidy ME, Yukna RA. Bone replacement grafts. The bone substitutes. Dent Clin North Am. 1998;42:491-503.
7. Banwart JC, Asher MA, Hassanein RS. Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine. 1995;20:1055-1060.
8. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma. 1989;3:192-195.
9. Helm GA, Dayoub H, Jane JA Jr. Bone graft substitutes for the promotion of spinal arthrodesis. Neurosurg Focus. 2001;10:E5.
10. Pilitsis JG, Lucas DR, Rengachary SS. Bone healing and spinal fusion. Neurosurg Focus. 2002;13:E1.
11. Rodrigues CV, Serricella P, Linhares AB, et al. Characterisation of a bovine collagen-hydroxyapatite composite scaffold for bone tissue engineering. Biomaterials. 2003;24:4987-4997.
12. Vitale-Brovarone C, Verné E, Robiglio L, et al. Development of glassceramic scaffolds for bone tissue engineering: characterisation, proliferation of human osteoblasts and nodule formation. Acta Biomater. 2007;3:199-208.
13. Vitale-Brovarone C, Verné E, Robiglio L, Martinasso G, Canuto RA, Muzio G. Biocompatible glass-ceramic materials for bone substitution. J Mater Sci Mater Med. 2008;19:471-478.
14. Ogden JA, Tóth-Kischkat A, Schultheiss R. Principles of shock wave therapy. Clin Orthop Relat Res. 2001;387:8-17.
15. Shrivastava SK, Kailash. Shock wave treatment in medicine. J Biosci. 2005;30:269-275.
16. Ko J, Chen H, Chen L. Treatment of lateral epicondylitis of the elbow with shock waves. Clin Orthop Relat Res. 2001;387:60-67. (Pubitemid 32510323)
17. Maier M, Steinborn M, Schmitz C, et al. Extracorporeal shock wave application for chronic plantar fasciitis associated with heel spurs: prediction of outcome by magnetic resonance imaging. J Rheumatol. 2000;27:2455-2462.
18. Wang FS, Yang KD, Kuo YR, et al. Temporal and spatial expression of bone morphogenetic proteins in extracorporeal shock wave-promoted healing of segmental defect. Bone. 2003;32:387-396.
19. Martini L, Giavaresi G, Fini M, et al. Shock wave therapy as an innovative technology in skeletal disorders: study on transmembrane current in stimulated osteoblast-like cells. Int J Artif Organs. 2005;28:841-847.
20. Ogden JA, Alvarez RG, Levitt R, Marlow M. Shock wave therapy (Orthotripsy® ) in muscoloskeletal disorders. Clin Orthop Relat Res. 2001;387:22-40. (Pubitemid 32510320)
21. Frairia R, Catalano MG, Fortunati N, Fazzari A, Raineri M, Berta L. High energy shock waves (HESW) enhance paclitaxel cytotoxicity in MCF-7 cells. Breast Cancer Res Treat. 2003;81:11-19.
22. Gough JE, Jones JR, Hench LL. Nodule formation and mineralization of human primary osteoblasts cultured on a porous bioactive glass scaffold. Biomaterials. 2004;25:2039-2046.
23. Cheng H, Jiang W, Phillips FM, et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am. 2003;85:1544-1552.
24. Yuan Y, Wu ZJ, Yao HY, et al. Activation of p38 mitogen-activated protein kinase contribute to BMP4-induced alkaline phosphatase expression in MC3T3-E1 preosteoblast. Chin Med J (Engl). 2006;119:324-327.
25. Sampath TK, Maliakal JC, Hauschka PV, et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem. 1992;267:20352-20362.
26. Bostrom MP. Expression of bone morphogenetic proteins in fracture healing. Clin Orthop Relat Res. 1998;355:S116-S123.
27. Sakou T. Bone morphogenetic proteins: from basic studies to clinical approaches. Bone. 1998;22:591-603.
28. Dean DB, Watson JT, Moed BR, Zhang Z. Role of bone morphogenetic proteins and their antagonists in healing of bone fracture. Front Biosci. 2009;14:2878-2888.